Key dangers include: Overdose or underdose: Errors in calculation can result in receiving far more or far less than the intended amount, leading to severe adverse effects or no therapeutic benefit Microbial contamination: Without pharmaceutical-grade manufacturing conditions, vials may be contaminated with bacteria or fungi, risking serious infection including sepsis Chemical degradation: Improper storage, incorrect diluent, or excessive agitation can degrade the peptide, producing unknown breakdown products Injection site complications: Subcutaneous injections performed without training can cause lipodystrophy, abscess formation, or nerve injury There is also a psychological dimension to consider
The median duration to new-onset dialysis was significantly longer in the GLP-1RA group (median: 1.9 years, interquartile range: 0.92.8 years) than in the DPP-4i group (median: 1.3 years, interquartile range: 0.62.4 years) (Fig
Most patients find abdomen easiest and least uncomfortable
Patients initiating GLP-1 therapy for diabetes or weight management who also experience joint pain should maintain a comprehensive approach to musculoskeletal health
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity Full Text View ClinicalTrials.gov
Highlights Semaglutide and tirzepatide work by mimicking naturally occurring hormones to suppress appetite and stabilize blood sugar
